February 27, 2015 3:04 AM ET


Company Overview of Aduro BioTech, Inc.

Executive Profile

Stephen T. Isaacs

Chairman, Chief Executive Officer and President, Aduro BioTech, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships


Mr. Stephen T. Isaacs serves as the Chairman, Chief Executive Officer and President of Aduro BioTech, Inc. Mr. Isaacs was the founder of Cerus Corporation and served as its President and Chief Executive Officer from September 1991 to May 10, 2004. While at Cerus, he led financings and partnerships providing over $250 million and negotiated major contracts with Baxter Healthcare Inc., the Consortium for Plasma Science, Kirin Pharmaceuticals and the Medimmune Corporation. ...

Corporate Headquarters

626 Bancroft Way
Berkeley, California 94710-2224

United States

Phone: 510-848-4400
Fax: 510-848-5614

Board Members Memberships

Chairman, Chief Executive Officer and President
Former Chief Executive Officer, President and Director


Bachelor's Degree 1973
University of California Berkeley

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aduro BioTech, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.